NO20040995L - Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus - Google Patents

Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus

Info

Publication number
NO20040995L
NO20040995L NO20040995A NO20040995A NO20040995L NO 20040995 L NO20040995 L NO 20040995L NO 20040995 A NO20040995 A NO 20040995A NO 20040995 A NO20040995 A NO 20040995A NO 20040995 L NO20040995 L NO 20040995L
Authority
NO
Norway
Prior art keywords
subunit vaccine
necrosis virus
pancreatic necrosis
infectious pancreatic
infectious
Prior art date
Application number
NO20040995A
Other languages
English (en)
Inventor
Vikram N Vakharia
Original Assignee
Univ Maryland Biotech Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Maryland Biotech Inst filed Critical Univ Maryland Biotech Inst
Publication of NO20040995L publication Critical patent/NO20040995L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/14011—Baculoviridae
    • C12N2710/14041—Use of virus, viral particle or viral elements as a vector
    • C12N2710/14043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vectore
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/10011—Birnaviridae
    • C12N2720/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
NO20040995A 2001-08-10 2004-03-09 Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus NO20040995L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US31148801P 2001-08-10 2001-08-10
PCT/US2002/025185 WO2003013597A1 (en) 2001-08-10 2002-08-12 Sub-unit vaccine for infectious pancreatic necrosis virus

Publications (1)

Publication Number Publication Date
NO20040995L true NO20040995L (no) 2004-04-29

Family

ID=23207100

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040995A NO20040995L (no) 2001-08-10 2004-03-09 Subenhetsvaksine for smittsom bukspyttkjertel-nekrosevirus

Country Status (5)

Country Link
US (1) US6936256B2 (no)
EP (1) EP1420819B1 (no)
CA (1) CA2457349A1 (no)
NO (1) NO20040995L (no)
WO (1) WO2003013597A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03008563A (es) * 2001-03-23 2005-03-07 Advanced Bionutrition Alimentos microbianos para acuacultural y agricultura.
ES2217967B1 (es) * 2003-03-31 2006-01-01 Consejo Sup. Investig. Cientificas Procedimiento de produccion de particulas virales vacias (vlps) del virus inductor de la bursitis infecciosa (ibdv), composiciones necesarias para su puesta a punto y su uso en la elaboracion de vacunas frente al ibdv.
ES2307346B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias (vlps(-vp4)) del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
ES2307345B1 (es) * 2004-01-21 2009-11-13 Consejo Sup. Investig. Cientificas Capsidas vacias quimericas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), su procedimiento de obtencion y aplicaciones.
WO2006041933A2 (en) * 2004-10-05 2006-04-20 Diversa Corporation Improved vaccines
US7244432B2 (en) * 2004-12-08 2007-07-17 University Of Maryland Biotechnology Institute Infectious bursal disease virus (IBDV) variant from Georgia
ES2310062B1 (es) * 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
WO2008140610A2 (en) * 2006-12-20 2008-11-20 Advanced Bionutrition Corporation Antigenicity of infectious pancreatic necrosis virus vp2 sub-viral particles expressed in yeast
AU2008337440B2 (en) * 2007-12-19 2013-05-02 Intervet International B.V. Vaccine antigens from Piscirickettsia salmonis
US20100330113A1 (en) * 2007-12-19 2010-12-30 Intervet International B.V. Vaccine Antigens
US9139618B2 (en) * 2010-12-29 2015-09-22 Intervet Inc. Salmonid alphavirus protein E2
US9732144B2 (en) * 2012-07-05 2017-08-15 Ohio State Innovation Foundation Infectious bursal disease (IBDV) vaccine compositions
CA2885333C (en) * 2012-09-26 2021-02-09 Fvg Limited Subunit immersion vaccines for fish
GB201309664D0 (en) * 2013-05-30 2013-07-17 Univ Aberdeen Fish vaccine
GB201400311D0 (en) * 2014-01-08 2014-02-26 Aqua Gen As Treating Susceptibility
WO2016005796A1 (en) * 2014-07-11 2016-01-14 Fundacion Fraunhofer Chile Research Agent with antiviral properties for preventing or treating individuals exposed to a virus of the birnaviridae family
US10792354B2 (en) * 2017-12-31 2020-10-06 University Of Maryland Baltimore County Feed additive composition for immunoprotection of fish against infectious viral species

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5165925A (en) * 1989-05-02 1992-11-24 State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University Vaccine for immunizing fish against infectious pancreatic necrosis virus
US5788970A (en) * 1994-03-29 1998-08-04 The University Of Maryland College Park Chimeric infectious bursal disease virus CDNA clones, expression products and vaccines based thereon
DK0712926T3 (da) * 1994-10-18 2004-02-09 Akzo Nobel Nv Virus, der forårsager bugspytkirtelsygdom hos fisk
US5780448A (en) * 1995-11-07 1998-07-14 Ottawa Civic Hospital Loeb Research DNA-based vaccination of fish
WO1999050419A2 (en) * 1998-03-31 1999-10-07 University Of Maryland Biotechnology Institute A method for generating nonpathogenic, infectious pancreatic necrosis virus (ipnv) from synthetic rna transcripts
WO1999058639A2 (en) * 1998-05-08 1999-11-18 Akzo Nobel N.V. Structural proteins of fish pancreatic disease virus and uses thereof

Also Published As

Publication number Publication date
US6936256B2 (en) 2005-08-30
EP1420819B1 (en) 2008-05-28
US20030072772A1 (en) 2003-04-17
WO2003013597A1 (en) 2003-02-20
CA2457349A1 (en) 2003-02-20
EP1420819A4 (en) 2005-09-28
EP1420819A1 (en) 2004-05-26

Similar Documents

Publication Publication Date Title
CY2016018I2 (el) Εμβολιο κατα του ιου του δυτικου νειλου
NO20021431D0 (no) Intranasal influensavirusvaksine
ATE553775T1 (de) Impstoffzusammesetzung
ATE420159T1 (de) Grippe-impfstoffzusammensetzung
FR14C0016I2 (fr) Vacccin west nile
NO20044326D0 (no) Virale antigener
IS7133A (is) Afleiða beta-amyloid - T-frumu-mótefnavísisbóluefni
EP1423141A4 (en) VACCINE
NO20033882L (no) Vaksine
IS7830A (is) Bóluefni gegn lifrarbólgu C veiru (HCV)
DK1523329T3 (da) Viruspartikeladjuvant
NO20030239D0 (no) Modifisert virus
IL158428A0 (en) Vaccine composition comprising at least one hiv virus antigen
EP1692279A4 (en) VIRUS PREPARATIONS CONTAINING A CONSERVATIVE
ATE392903T1 (de) Impfstoff gegen pferdeherpesvirus
EP1429615A4 (en) ORAL VACCINES
EP1539938A4 (en) CHIMERIC GB-VIRUS B (GBV-B)
IS2797B (is) Bóluefni gegn ISA-veiru
AU2002355428A1 (en) Sub-unit vaccine for infectious pancreatic necrosis virus
SI1436397T1 (sl) Cepivo proti virusu hepatitisa C
NO20012126D0 (no) HIV-vaksine
DK2258850T3 (da) Rekombinante virusbaserede malariavacciner
ATA6392001A (de) Atmosphärischer brenner
DK1299395T3 (da) Oxazinoquinoloner til behandling af virusinfektioner
AU2002319246A1 (en) White spot syndrome virus vaccine

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application